Treatment of heterotypic spheroids co-cultured with immune cells added to supernatants with CEA TCB or FAP TCB resulted in target-specific cross-linking and retention of T cells to tumor cells or fibroblast areas (Fig. 5a, b), respectively. The gene discussed is FAP; the disease is neoplasm.